Physician profile
Kristen Patrick
NPI 1053760173
$370.07
in general payments reported to CMS, 2019-2025
11 companies · $50.89 in 2025
The $50.89 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.85 · 2021: $151 · 2022: $15.04 · 2023: $50.29 · 2024: $83.31 · 2025: $50.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $184.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $65.35 | 2024 | Doc Band |
| Takeda Pharmaceuticals U.S.A., INC. | $48.96 | 2021 | |
| Merck Sharp & Dohme LLC | $41.12 | 2021-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Collegium Pharmaceutical, INC. | $36.85 | 2025 | Jornay Pm |
| Seqirus USA INC | $35.68 | 2023 | Flucelvax Quadrivalent |
| Corium, LLC | $32.25 | 2021-2022 | |
| Pfizer INC. | $32.05 | 2021 | |
| Tris Pharma INC | $20.47 | 2021 | |
| Glaxosmithkline, LLC. | $19.85 | 2020 | |
| Supernus Pharmaceuticals, INC. | $19.53 | 2021 | |
| Ironshore Pharmaceuticals INC. | $17.96 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristen Patrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.